Company
Our vision
PlasmAcute aims to obtain earlier diagnosis of infections in the human and veterinary field as compared to the current standard. Through earlier diagnosis, PlasmAcute aims to enable appropriate disease management, thereby potentially reducing disease complications, improving quality of life, and saving costs to health care providers.
Key strategy elements
Several studies and development projects are currently being launched, in the following fields of interest:
- Clinical studies both in humans and animals where early diagnosis is of high importance
- Studies on early antibody composition and localisation, and the kinetics of the immune response
- Development of a Point of Care application